Stock Research: Illumina

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Illumina

NSQ:ILMN US4523271090
84
  • Value
    10
  • Growth
    97
  • Safety
    Safety
    54
  • Combined
    63
  • Sentiment
    64
  • 360° View
    360° View
    84
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Illumina, Inc. provides sequencing-and array-based solutions for genetic and genomic analysis. It operates in the genomic research and clinical settings industries. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, and others. In the last fiscal year, the company had a market cap of $15,498 million, profits of $2,861 million, revenue of $4,372 million and 8970 employees.

more

ANALYSIS: With an Obermatt 360° View of 84 (better than 84% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Illumina are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Illumina. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 97% of competitors in the same industry. The consolidated Safety Rank at 54 means that the company has a financing structure that is safer than 54% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 64, which means that professional investors are more optimistic about the stock than for 64% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 10, meaning that the share price of Illumina is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 90% of alternative stocks in the same industry. ...read more

more
Index
NASDAQ
D.J. US Health Care
S&P MIDCAP
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 23-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 35 12 3
Growth
97 55 7 85
Safety
Safety
54 51 48 32
Sentiment
64 93 4 1
360° View
360° View
84 73 1 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
13 24 13 4
Opinions Change
34 90 52 12
Pro Holdings
n/a 78 6 29
Market Pulse
45 70 21 26
Sentiment
64 93 4 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 35 12 3
Growth
97 55 7 85
Safety Safety
54 51 48 32
Combined
63 36 4 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
36 52 36 19
Price vs. Earnings (P/E)
27 59 8 4
Price vs. Book (P/B)
22 27 45 37
Dividend Yield
1 1 1 1
Value
10 35 12 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
38 24 10 45
Profit Growth
91 96 8 62
Capital Growth
65 51 79 89
Stock Returns
81 41 25 65
Growth
97 55 7 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
28 20 40 46
Refinancing
51 33 19 17
Liquidity
85 79 80 62
Safety Safety
54 51 48 32

Similar Stocks

Discover high‑ranked alternatives to Illumina and broaden your portfolio horizons.

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: